The Subject Patent Already Has Underlining or ... - Bayhdolecentral
The Subject Patent Already Has Underlining or ... - Bayhdolecentral
The Subject Patent Already Has Underlining or ... - Bayhdolecentral
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
izations to charge fees under 37 CPR 1.16 do not<br />
constitute a specific auth<strong>or</strong>ization to charge national<br />
stage fees.<br />
1893.01(d) Translation<br />
Applicants entering the national stage in the U.S.<br />
are required to file a translation of the international<br />
application (if the international application was filed<br />
in another language). 35 U.S.C. 37l(c)(2). A<br />
"Sequence Listing" need not be translated if the<br />
"Sequence Listing" complies with peT Rule l2.l(d)<br />
and the description complies with PCT Rule 5.2(b).<br />
See 37 CPR 1,495(c). <strong>The</strong> translation must be a translation<br />
of the international application as filed with any<br />
changes which have been properly accepted under<br />
PCT Rule 26 <strong>or</strong> any rectifications which have been<br />
properly accepted under PCT Rille 91. Amendments,<br />
even those considered to be ntin<strong>or</strong> <strong>or</strong> to not include<br />
new matter, may not be inc<strong>or</strong>p<strong>or</strong>ated into the translation.<br />
If an amendment to the international application<br />
as filed is desired f<strong>or</strong> the national stage, it may be subntitted<br />
in acc<strong>or</strong>dance with 37 CPR 1.121. An amendment<br />
filed under 37 CPR 1.121 should be subntitted<br />
within 1 month after completion of the 35 U.S.c.<br />
37l(c) requirements and entry into the national stage.<br />
See 37 CPR 1.496(a). If applicant has timely paid the<br />
basic national fee but the translation is missing <strong>or</strong> is<br />
defective, a notice of Missing Requirements will be<br />
sent to applicant setting a period to c<strong>or</strong>rect any missing<br />
<strong>or</strong> defective requirements. <strong>The</strong> time period is<br />
21 months <strong>or</strong> 31 months from the pri<strong>or</strong>ity date, as<br />
appropriate, <strong>or</strong> 1 month from the date of the notice,<br />
whichever expires later. <strong>The</strong> time period is subject to<br />
the provisions of 37 CPR1.136(a).<br />
1893.01(e) OathIDeclaration<br />
37 CFR 1.497. Oath <strong>or</strong> declaration under 35 U.S.c.<br />
371(c)(4).<br />
(a) When an applicant of an international application desires<br />
to enter the national stage under 35 U.S.C. 371 pursuant to<br />
§§ 1.494 <strong>or</strong> 1.495, and a declaration in compliance with this section<br />
has not been previously submitted in the international application<br />
under peT Rule 4.l7(iv) within the time limits provided<br />
f<strong>or</strong> in peT Rule 26 ter.l, he <strong>or</strong> she must file an oath <strong>or</strong> declaration<br />
that:<br />
(1) Is executed in acc<strong>or</strong>dance with either §§ 1.66 <strong>or</strong> 1.68;<br />
(2) Identifies 'the specification to which it is directed;<br />
(3) Identifies each invent<strong>or</strong> and the country of citizenship<br />
of each invent<strong>or</strong>; and<br />
PATENT COOPERATION TREATY 1893.01(e)<br />
(4) States that the person making the oath <strong>or</strong> declaration<br />
believes the named invent<strong>or</strong> <strong>or</strong> invent<strong>or</strong>s to. be the <strong>or</strong>iginal and<br />
first invent<strong>or</strong> <strong>or</strong> invent<strong>or</strong>s of the subject matter which is claimed<br />
and f<strong>or</strong> which a patent is sought.<br />
(b)(I) <strong>The</strong> oath <strong>or</strong> declaration must be made by all of the<br />
actual invent<strong>or</strong>s except as provided f<strong>or</strong> in §§ 1.42, 1.43 <strong>or</strong> 1.47.<br />
(2) If the person 'making the oath <strong>or</strong> declaration <strong>or</strong> any<br />
supplemental oath <strong>or</strong> declaration is not the invent<strong>or</strong> (§§ 1.42, 1.43,<br />
<strong>or</strong> §1.47), the oath <strong>or</strong> declaration shall state the relationship of the<br />
person to the invent<strong>or</strong>, and,upon inf<strong>or</strong>mation and belief, the facts<br />
which the invent<strong>or</strong>.would have been required to state. If the person<br />
signing the oath <strong>or</strong> declaration is the legal representative of a<br />
deceased invent<strong>or</strong>, the oath <strong>or</strong> declaration shall also state that the<br />
person is a legal representative and the citizenship, residence and<br />
mailing address of the legal representative.<br />
(c) <strong>Subject</strong> to paragraph (f) of this 'section, if the oath <strong>or</strong><br />
declaration meets the requirements of paragraphs (a) and (b) of<br />
this section, the oath <strong>or</strong> declaration will be accepted as.complying<br />
with 35 U.S.C. 371(c)(4) and §§ 1.494(c) <strong>or</strong> 1.495(c). However, if<br />
the oath <strong>or</strong> declaration does not also meet the requirements of<br />
§' 1.63, a supplemental oath <strong>or</strong> declaration in compliance with<br />
§ 1.63 <strong>or</strong> an application data sheet will be required in acc<strong>or</strong>dance<br />
with § 1.67.<br />
(d) If the oath <strong>or</strong> declaration flled pursuant to 35 U.S.c.<br />
371(c)(4) and this,section names 'an inventive entity different from<br />
the inventive entity set f<strong>or</strong>th in the international application, '<strong>or</strong> a<br />
change to the inventive entity has been effected under PCT Rule<br />
92 bis subsequent to the execution' of any' declaration which was<br />
filed under PCT Rule 4. 17(iv), the oath <strong>or</strong> declaration must be<br />
accompanied by;<br />
(l) A statement from each person being added as an<br />
invent<strong>or</strong> and from each person being deleted as an invent<strong>or</strong> that<br />
any err<strong>or</strong> ininvent<strong>or</strong>ship in the international application occurred<br />
without deceptive intention on his <strong>or</strong> her part;<br />
(2) <strong>The</strong> processing fee set f<strong>or</strong>th in § 1.17(i): and<br />
(3) Ifan assignment has been executedby any of the <strong>or</strong>iginal<br />
named invent<strong>or</strong>s, the written consent of the assignee (see §<br />
3.73(b) of this chapter).<br />
(e) <strong>The</strong> Office mayrequire such other inf<strong>or</strong>mation as may be<br />
deemed appropriate under the particular circumstances surrounding<br />
the c<strong>or</strong>rection of invent<strong>or</strong>ship.<br />
(f) A new oath <strong>or</strong> declaration in acc<strong>or</strong>dance with this section<br />
must be filed to satisfy 35 U.S.c. 371(c)(4) if the declaration was<br />
filed under PCT Rule 4.17(iv), and:<br />
(1) <strong>The</strong>re was a change in the international filing date<br />
pursuant to PeT Rule 20.2 after the declaration was executed; <strong>or</strong><br />
(2) A'change in the inventive entitywas' effected under<br />
PCTRule 92 bis after the declarationwas executed.<br />
(g) If a pri<strong>or</strong>ity claim has been c<strong>or</strong>rected <strong>or</strong> added pursuant<br />
to PCT Rule 26bis during the international stage after the declaration<br />
of invent<strong>or</strong>ship was executed in the international application<br />
under PST Rule 4.17(iv), applicant will be required to submit<br />
either a new oath <strong>or</strong> declaration <strong>or</strong> an application data sheet as set<br />
f<strong>or</strong>th in § 1.76 c<strong>or</strong>rectly identifying the application upon which<br />
pri<strong>or</strong>ity is claimed.<br />
1800c139 August 2001